During the past decade, Aiken Center for Clinical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aiken Center for Clinical Research" are "Diabetes Mellitus, Type 2" (2 trials), "Diabetic Neuropathy, Painful" (1 trials) and "Renal Insufficiency" (1 trials). Many other conditions were trialed in "Aiken Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Aiken Center for Clinical Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "vildagliptin" (2 trials), "Placebo" (1 trials), "Sitagliptin" (1 trials), "pregabalin (Lyrica)" (1 trials) and "sitagliptin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aiken Center for Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Aiken Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aiken Center for Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aiken Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".